Panion Animal Health is specialised in the development of gene therapy for the treatment of epilepsy in dogs and other pets. The products consist of a number of veterinary products and other forms of treatment. Today business is operated in Europe and North America. The company was established in 2005 as a subsidiary of CombiGene. The company is based in Hässleholm.

Quotes for Panion Animal Health AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Anja Holm

Chairperson of the Board

  • Arne Ferstad

Board

  • Jan Nilsson
  • Lars Thunberg

Videos

Largest Owners

Name Capital % Votes % Date
Combigene AB 91,42 91,42 2019-09-30
Lars Thunberg 11,90 11,90 2019-07-03
Patrik Kazimiersky 5,83 5,83 2018-03-31
Avanza Pension 0,54 0,54 2019-09-30
Anja Holm 0,54 0,54 2018-06-04
Stefan Jonsson 0,41 0,41 2019-09-30
Johan Sivander 0,38 0,38 2019-09-30
Sofia Josephson 0,27 0,27 2018-06-04
Lars Friis Mikkelsen 0,26 0,26 2019-09-30
Henrik Amilon 0,23 0,23 2019-09-30

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream